V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330011274 | 330003609 | null | 57.7 | Neo-adjuvant (N) | null | 2014-04-09 | METHOTREXATE | N | null | 330005325 | METHOTREXATE |
| 330011275 | 330003611 | 1.82 | null | Curative (C) | 2015-08-02 | 2015-11-09 | OST Euramos 1 Closed Trial - A | Y | N | 330005334 | DOXORUBICIN |
| 330011276 | 330003614 | null | 83 | Curative (C) | null | 2015-08-26 | MIFAMURTIDE | Y | null | 330005358 | MIFAMURTIDE |
| 330011277 | 330003616 | 0 | 55.5 | Adjuvant (A) | 2015-04-25 | 2015-09-05 | MIFAMURTIDE | Y | N | 330005388 | MIFAMURTIDE |
| 330011278 | 330003621 | null | 74.9 | Curative (C) | 2015-11-30 | 2016-07-12 | DOXORUBICIN | N | N | 330005418 | DOXORUBICIN |
| 330011279 | 330010316 | 1.85 | 68.9 | Curative (C) | 2014-03-27 | 2014-03-30 | Trial Unspecified | Y | N | 330005439 | TRIAL |
| 330011280 | 330003626 | 1.74 | null | Neo-adjuvant (N) | 2015-09-11 | 2016-06-30 | DOXORUBICIN | N | N | 330005461 | DOXORUBICIN |
| 330011281 | 330003631 | 1.91 | 47.7 | Neo-adjuvant (N) | 2018-03-17 | 2018-03-23 | EW EuroEwing 2012 Arm B IE | 02 | N | 330005520 | TRIAL |
| 330011282 | 330003636 | 1.82 | 83 | Adjuvant (A) | 2018-10-20 | 2018-11-17 | Cisplatin 7 day | N | N | 330005522 | CISPLATIN |
| 330011283 | 330003640 | 1.83 | null | Adjuvant (A) | 2012-10-08 | 2015-01-01 | DOXORUBICIN | Y | N | 330005550 | DOXORUBICIN |
| 330011284 | 330003643 | 1.68 | 77.1 | Curative (C) | null | 2018-02-28 | DOXORUBICIN | Y | null | 330005564 | DOXORUBICIN |
| 330011285 | 330003645 | 1.66 | 55.5 | Palliative (P) | 2016-07-10 | 2016-07-14 | EW EuroEwing 2012 Arm B VDC | null | null | 330005587 | TRIAL |
| 330011286 | 330012354 | 1.76 | null | Palliative (P) | 2018-01-25 | 2018-02-10 | Trial Unspecified | N | N | 330005613 | TRIAL |
| 330011287 | 330003648 | 1.75 | null | Disease modification (D) | 2017-09-16 | 2017-09-19 | EW EuroEwing 2012 Arm A VAI | N | Y | 330005616 | TRIAL |
| 330011288 | 330003653 | 1.66 | 55 | Curative (C) | 2017-02-01 | 2017-02-01 | EW EuroEwing 2012 Arm B VDC | 2 | N | 330005625 | TRIAL |
| 330011289 | 330003659 | 1.76 | 16.3 | Curative (C) | 2017-06-29 | 2017-06-29 | Mifamurtide weeks 1-12 | 01 | N | 330005676 | MIFAMURTIDE |
| 330011290 | 330003661 | 1.69 | 58.5 | Curative (C) | 2017-10-06 | 2017-10-07 | EW EuroEwing 2012 Arm B IE | N | Y | 330005682 | TRIAL |
| 330011291 | 330003671 | null | 54.8 | Neo-adjuvant (N) | null | 2016-04-27 | MIFAMURTIDE | N | null | 330005694 | MIFAMURTIDE |
| 330011292 | 330003677 | 1.66 | 85 | Neo-adjuvant (N) | 2016-12-15 | 2017-02-06 | Cisplatin | N | N | 330005702 | CISPLATIN |
| 330011293 | 330003682 | 1.78 | 22 | Curative (C) | 2014-10-08 | 2014-10-08 | Doxorubicin 75mg/m2 | Y | N | 330005721 | DOXORUBICIN |
| 330011294 | 330003683 | 1.67 | null | Adjuvant (A) | 2017-12-01 | 2017-12-21 | DOXORUBICIN | 2 | Y | 330005732 | DOXORUBICIN |
| 330011295 | 330007985 | 1.69 | 61.4 | Curative (C) | 2016-12-11 | 2017-09-05 | Mifamurtide weeks 1-12 | 02 | N | 330005735 | MIFAMURTIDE |
| 330011296 | 330003690 | 1.61 | 83.75 | Neo-adjuvant (N) | 2015-03-21 | 2015-03-21 | EW EuroEwing 2012 Arm A VAI | N | null | 330005768 | TRIAL |
| 330011297 | 330013011 | 1.64 | 80 | Curative (C) | 2015-07-09 | 2015-07-24 | METHOTREXATE | 01 | N | 330005860 | METHOTREXATE |
| 330011298 | 330003695 | null | 37.8 | null | 2015-12-21 | 2015-12-27 | Mifamurtide weeks 1-12 | N | Y | 330005861 | MIFAMURTIDE |
| 330011299 | 330003698 | 1.78 | 46.4 | Adjuvant (A) | 2015-08-16 | 2015-12-30 | Mifamurtide weeks 1-12 | 01 | N | 330005868 | MIFAMURTIDE |
| 330011300 | 330003703 | 1.77 | 22 | Curative (C) | 2016-09-06 | 2017-01-11 | METHOTREXATE | N | N | 330005885 | METHOTREXATE |
| 330011301 | 330003704 | 1.82 | 81 | Neo-adjuvant (N) | 2015-10-29 | 2016-10-04 | Trial Unspecified | Y | null | 330005891 | TRIAL |
| 330011302 | 330003707 | 1.81 | 75.1 | Palliative (P) | null | 2019-03-13 | EW EuroEwing 2012 Arm B VDC | N | null | 330005922 | TRIAL |
| 330011305 | 330003718 | 1.74 | null | null | 2015-10-29 | 2015-12-26 | Cisplatin | N | N | 330005948 | CISPLATIN |
| 330011306 | 330003720 | 1.79 | 58.5 | Curative (C) | 2016-10-26 | 2016-10-26 | Trial Unspecified | N | N | 330005950 | TRIAL |
| 330011309 | 330003724 | 1.6 | 83 | Curative (C) | 2015-01-01 | 2015-01-10 | Trial Unspecified | N | N | 330006003 | TRIAL |
| 330011310 | 330003727 | 1.73 | 56 | Curative (C) | 2015-03-18 | 2015-06-23 | DOXORUBICIN | 01 | N | 330006006 | DOXORUBICIN |
| 330011311 | 330003730 | 1.47 | 28.6 | null | 2014-09-02 | 2015-02-11 | Trial Unspecified | N | N | 330006015 | TRIAL |
| 330011312 | 330003731 | 1.82 | 46 | Neo-adjuvant (N) | 2016-03-03 | 2016-03-10 | Trial Unspecified | N | null | 330006016 | TRIAL |
| 330011313 | 330003740 | 1.8 | 71.8 | Adjuvant (A) | 2013-08-21 | 2013-08-31 | METHOTREXATE | Y | N | 330006058 | METHOTREXATE |
| 330011314 | 330008019 | 1.77 | 71.6 | Curative (C) | 2014-02-19 | 2014-04-13 | Trial Unspecified | 02 | N | 330006497 | TRIAL |
| 330011315 | 330003750 | null | 50.3 | Palliative (P) | null | 2014-09-18 | METHOTREXATE | Y | null | 330006926 | METHOTREXATE |
| 330011316 | 330003753 | 1.91 | 68.4 | Adjuvant (A) | null | 2017-08-17 | Mifamurtide weeks 13-36 | null | null | 330007189 | MIFAMURTIDE |
| 330011317 | 330003754 | 1.74 | 74.9 | Neo-adjuvant (N) | 2013-04-28 | 2013-05-10 | Mifamurtide weeks 13-36 | 02 | Y | 330007195 | MIFAMURTIDE |
| 330011318 | 330013157 | 0 | 90 | Adjuvant (A) | 2016-08-17 | 2016-08-17 | OST Mifamurtide | N | N | 330007212 | MIFAMURTIDE |
| 330011320 | 330003759 | 1.77 | 52.35 | Curative (C) | null | 2017-01-18 | OST Mifamurtide | null | null | 330007214 | MIFAMURTIDE |
| 330011321 | 330003761 | 1.6 | 67.4 | null | 2013-12-21 | 2014-07-29 | OST Euramos 1 Closed Trial - A | 02 | N | 330007218 | DOXORUBICIN |
| 330011322 | 330003764 | 1.6 | 31.9 | Neo-adjuvant (N) | 2013-10-19 | 2014-04-20 | DOXORUBICIN | 1 | N | 330007247 | DOXORUBICIN |
| 330011323 | 330003768 | 1.68 | null | Curative (C) | null | 2014-12-06 | Mifamurtide weeks 1-12 | N | null | 330007248 | MIFAMURTIDE |
| 330011324 | 330003770 | 0 | 88 | Curative (C) | 2015-12-30 | 2016-01-03 | Trial Unspecified | 02 | N | 330007251 | TRIAL |
| 330011325 | 330008035 | 1.81 | 81 | Palliative (P) | 2015-04-21 | 2015-05-21 | Trial Unspecified | N | null | 330007251 | TRIAL |
| 330011326 | 330003774 | 1.7 | 58.4 | Palliative (P) | 2017-04-01 | 2017-04-01 | Mifamurtide weeks 1-12 | 01 | N | 330007271 | MIFAMURTIDE |
| 330011327 | 330003779 | 1.7 | null | Palliative (P) | 2016-01-09 | 2016-02-06 | Trial Unspecified | 02 | N | 330007311 | TRIAL |
| 330011328 | 330010362 | 1.68 | 109.2 | Curative (C) | 2013-11-27 | 2013-11-28 | DOXORUBICIN | null | Y | 330007345 | DOXORUBICIN |